Hui Dang
Compliance Officer chez Shenyang Sunshine Pharmaceuticals Co., Ltd.
Profil
Hui Dang is currently the Director of Risk & Compliance Management at Shenyang Sunshine Pharmaceuticals Co., Ltd.
She previously worked as the Managing Director and Head of Risk & Compliance at 3SBio, Inc.
Postes actifs de Hui Dang
| Sociétés | Poste | Début |
|---|---|---|
Shenyang Sunshine Pharmaceuticals Co., Ltd.
 Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Compliance Officer | 01/08/1999 |
Anciens postes connus de Hui Dang
| Sociétés | Poste | Fin |
|---|---|---|
| 3SBIO INC. | Compliance Officer | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| 3SBIO INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Health Technology |
